Fuse Medical, Inc. Gross Profit

• Fuse Medical, Inc. showed a decrease of -3.3% in Gross Profit from 2021 to 2022.
• This data is from Fuse Medical, Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2023.
• XBRL data for this metric is available from 2013 to 2022 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2012: $345.3 thousand | Q1 2013: $251.4 thousand | Q2 2013: $118.6 thousand | Q3 2013: $175.1 thousand | Q4 2013: $194.4 thousand | Q1 2014: $102.7 thousand | Q2 2014: $158.6 thousand | Q3 2014: $134.4 thousand | Q1 2015: $169.1 thousand | Q2 2015: $309.1 thousand | Q3 2015: $277.6 thousand | Q1 2016: $111.7 thousand | Q2 2016: $99.8 thousand | Q3 2016: $65.0 thousand | Q1 2017: $2.53 million | Q2 2017: $2.77 million | Q3 2017: $2.74 million | Q1 2018: $2.88 million | Q2 2018: $1.95 million | Q3 2018: $3.74 million | Q1 2019: $2.80 million | Q2 2019: $2.85 million | Q3 2019: $928.4 thousand | Q1 2020: $2.65 million | Q2 2020: $2.21 million | Q3 2020: $3.69 million | Q1 2021: $2.59 million | Q2 2021: $3.45 million | Q3 2021: $2.39 million | Q1 2022: $2.81 million | Q2 2022: $2.94 million | Q3 2022: $3.05 million | Q1 2023: $2.82 million | Q2 2023: $3.47 million.
• Over the full 10 years of available data (2013 to 2022), Fuse Medical, Inc.'s Gross Profit has grown by 1,248.6%.
• Historical annual values: Fiscal year 2022: $11.54 million | Fiscal year 2021: $11.94 million | Fiscal year 2020: $12.70 million | Fiscal year 2019: $11.14 million | Fiscal year 2018: $12.99 million | Fiscal year 2017: $11.82 million | Fiscal year 2016: $14.41 million | Fiscal year 2015: $1.01 million | Fiscal year 2014: $455.7 thousand | Fiscal year 2013: $855.8 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026